2-Oxo-3,4-dihydropyrimido[4,5-d] pyrimidines as new reversible inhibitors of EGFR C797S (Cys797 to Ser797) mutant
31
The authors appreciate the financial support from the National Natural Science Foundation of China ;Guangdong International Science and TechnologyCooperation Project ;Guangzhou City KeyLaboratory of Precision Chemical Drug Development ;and Institutes for Drug Discovery and Develop-ment of Chinese Academy of Science
2020-07-23(万方平台首次上网日期,不代表论文的发表时间)
共7页
1281-1287